PharmaHub · Other Pharma & Biotech · Global

Coronary Artery Bypass Graft Cabg Market: Market Size & Forecast 2026

The coronary artery bypass graft (CABG) market encompasses surgical devices, graft materials, instruments, and biologics used in procedures that restore blood flow to the heart by bypassing blocked coronary arteries. Valued at approximately $3.1 billion in 2025, the market is projected to grow at a 6.4% compound annual growth rate, driven by the global burden of cardiovascular disease and demographic aging. Key growth forces include rising prevalence of coronary artery disease, increasing adoption of advanced minimally invasive surgical techniques, and expanding access to cardiac care in developing regions. Ongoing innovations in graft materials and hybrid procedural approaches are further shaping the market trajectory.

Market size · 2025
$3.1 billion
CAGR · 2025–2030
6.4%
Forecast · 2030
$4.2 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $3.1bn2030 est: $4.2bn
Read the full Coronary Artery Bypass Graft Cabg Market report →

Market Overview

CABG surgery remains a cornerstone intervention for patients with severe coronary artery disease, particularly those with multivessel blockages or left main disease. The market spans products including arterial and venous conduit grafts, surgical stabilizers, heart-positioning systems, and imaging technologies used during procedures. Sustained demand is underpinned by the continued global prominence of ischemic heart disease as a leading cause of mortality and the established clinical guidelines favoring surgical revascularization for complex cases.

  • Arterial grafts, particularly internal thoracic artery conduits, are increasingly preferred for their superior long-term patency rates compared to venous grafts
  • The market encompasses both traditional sternotomy approaches and newer minimally invasive and robotic-assisted surgical platforms
  • Procedure volumes remain significant across both developed and developing healthcare systems as coronary disease prevalence rises

Growth Drivers

The escalating global incidence of coronary artery disease, fueled by lifestyle-related risk factors including obesity, diabetes, and hypertension, is the primary demand catalyst for CABG procedures and associated products. An aging worldwide population contributes substantially, as cardiovascular disease risk escalates markedly with advancing age. Expanding healthcare infrastructure, rising insurance coverage, and improving surgical outcomes are collectively broadening patient access to these life-saving interventions.

  • Cardiovascular diseases remain the leading cause of death globally, sustaining strong demand for effective revascularization therapies including surgical bypass
  • Technological advancements in off-pump and minimally invasive CABG techniques reduce procedural risks and recovery times, making surgery viable for broader patient populations
  • Emerging markets are experiencing growing demand as economic development expands healthcare spending and cardiac surgery capabilities
Want a deeper cut on Coronary Artery Bypass Graft Cabg Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is segmented by graft type into arterial conduits, including internal thoracic and radial arteries, and venous grafts predominantly using the saphenous vein. Surgical approach categories include conventional on-pump CABG, off-pump beating-heart procedures, and minimally invasive direct coronary artery bypass. Geographically, North America commands the largest share supported by sophisticated healthcare systems and high procedure volumes, while the Asia-Pacific region is anticipated to exhibit the strongest growth trajectory.

  • North America leads in market share due to high disease prevalence, favorable reimbursement environments, and rapid adoption of advanced surgical technologies
  • Europe represents a mature but stable market characterized by aging demographics and well-established cardiac surgery programs across major healthcare systems
  • Asia-Pacific is the fastest-expanding region, driven by rising coronary disease burden, growing healthcare investment, and increasing procedural capabilities in countries including China, India, and Japan

Trends and Outlook

What are the recent trends and outlook?

Minimally invasive and robotic-assisted CABG procedures are gaining clinical momentum as they deliver reduced surgical trauma, shorter hospitalization, and accelerated patient recovery relative to conventional open-chest approaches. The development of bioengineered and tissue-engineered vascular grafts seeks to overcome limitations associated with native vessel harvesting, including donor site morbidity and long-term durability concerns. Hybrid revascularization strategies combining surgical bypass with catheter-based interventions are expanding treatment possibilities for patients with complex coronary anatomies.

  • Robotically assisted totally endoscopic CABG is emerging as a transformative technology with potential for broader adoption as surgeon training programs expand and equipment costs moderate
  • Clinical evidence favoring arterial grafts over venous grafts for long-term patency is driving shifts in surgical practice patterns and graft selection strategies
  • Integration of advanced imaging, intraoperative navigation, and artificial intelligence tools is enhancing surgical precision and procedural decision-making in the operating room
Talk to a Claight analyst
Do you want to research Coronary Artery Bypass Graft Cabg Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.